All In Biotech

Free tool

FAERS Monitor: Zanaflex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021447 or its brand name (Zanaflex, Tizanidine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

18,291

Serious

10,734

59% of reports

Hospitalization

5,347

Death reported

898

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue1,549
  • nausea1,482
  • pain1,479
  • headache1,431
  • drug ineffective1,265
  • fall1,047
  • dizziness950
  • dyspnoea899
  • diarrhoea896
  • arthralgia824
  • vomiting788
  • depression777
  • asthenia768
  • back pain741
  • anxiety699

Reports by year received

View as table
YearReports
2004314
2005356
2006337
2007237
2008314
2009364
2010494
2011521
2012700
2013584
2014727
20151,094
20161,403
20171,034
20181,054
20191,013
2020992
2021867
20221,234
20231,187
20241,249
20251,269
2026946

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,868 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
depressionSignal7773.93.71,712
back painSignal7413.73.41,452
fallSignal1,0473.63.42,014
anxietySignal6992.82.6834
painSignal1,4792.82.61,721
headacheSignal1,4312.62.51,483
astheniaSignal7682.42.2605
fatigueSignal1,5492.32.21,166
arthralgiaSignal8242.32.1603
dizzinessSignal9502.22.1629
nauseaSignal1,4822.22.1951
vomiting7881.91.8359
dyspnoea8991.81.7345
diarrhoea8961.61.5205
drug ineffective1,2651.11.013

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.